Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase
- 27 September 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (43) , 6172-6180
- https://doi.org/10.1038/sj.onc.1204751
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 57 references indexed in Scilit:
- Phosphorylation and Proteasome-Dependent Degradation of Bcl-2 in Mitotic-Arrested Cells after Microtubule DamageBiochemical and Biophysical Research Communications, 1999
- Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cellsOncogene, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- Importance of the Bcl-2 family in cell death regulationCellular and Molecular Life Sciences, 1996
- Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hairCell, 1993
- Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric MiceScience, 1993
- Male and Female Artistry in AfricaAfrican Arts, 1986
- Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18Cell, 1985
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970